Ikvaxone-S Injection
Marketer
Ikvans Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ikvaxone-S Injection
Combiflox, an injectable medication, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administer this medication strictly under medical guidance; adhere rigorously to the prescribed dosage schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or respiratory distress. Inform your physician about all current medications, and pregnant or lactating individuals must consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, driving should be avoided if drowsiness or dizziness occur. For optimal recovery, prioritize rest, a nutritious diet, and ample hydration. Your physician may order lab tests to monitor the drug's effects.
Uses of Ikvaxone-S Injection
Infections caused by bacteria
Major Benefits of Ikvaxone-S Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ikvaxone-S Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ikvaxone-S Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ikvaxone-S Injection works:
Ikvaxone-S Injection unites Ceftriaxone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance, optimizing Ceftriaxone's effectiveness by neutralizing enzymes that would otherwise degrade it.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Ikvaxone-S Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injection, Ikvaxone-S, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Ikvaxone-S Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ikvaxone-S Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ikvaxone-S Injection's application in individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Ikvaxone-S Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Ikvaxone-S Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ikvaxone-S Injection :
Should you forget a scheduled Ikvaxone-S Injection, seek your physician's advice.
Facts to Know About Ikvaxone-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently